LIPITOR

Generic: ATORVASTATIN CALCIUM

Manufacturer: Parke-Davis Div Of Pfizer Inc

HMG-CoA Reductase Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Platelet Aggregation Inhibitor [EPC]Loop Diuretic [EPC]Corticosteroid [EPC]
240,187
Total Reports
58,108
Serious Reports
18,380
Death Reports
30
Reported Reactions
Death Report Ratio: High (7.65%)

Patient Demographics

Male
102,550
Female
121,270

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for LIPITOR.

# Reaction Reports % of Total
1 FATIGUE 13,810
5.7%
2 DRUG INEFFECTIVE 12,859
5.3%
3 NAUSEA 12,421
5.1%
4 TYPE 2 DIABETES MELLITUS 11,242
4.7%
5 DIARRHOEA 11,037
4.6%
6 DYSPNOEA 11,025
4.6%
7 PAIN 10,048
4.2%
8 MYALGIA 9,805
4.1%
9 DIZZINESS 9,710
4.0%
10 HEADACHE 9,650
4.0%
11 ASTHENIA 8,838
3.7%
12 ARTHRALGIA 8,509
3.5%
13 PAIN IN EXTREMITY 8,171
3.4%
14 FALL 7,834
3.2%
15 DEATH 7,432
3.1%
16 OFF LABEL USE 7,023
2.9%
17 MALAISE 6,888
2.9%
18 WEIGHT DECREASED 6,765
2.8%
19 MYOCARDIAL INFARCTION 6,659
2.8%
20 VOMITING 6,320
2.6%
21 PNEUMONIA 6,007
2.5%
22 COUGH 5,908
2.4%
23 DRUG HYPERSENSITIVITY 5,863
2.4%
24 MUSCLE SPASMS 5,599
2.3%
25 PRURITUS 5,533
2.3%
26 RASH 5,424
2.2%
27 BACK PAIN 5,381
2.2%
28 CEREBROVASCULAR ACCIDENT 5,320
2.2%
29 HYPERTENSION 5,164
2.1%
30 CHEST PAIN 5,113
2.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.